Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04474301 · ClinicalTrials.gov registry record
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
A clinical trial of Melanoma and COVID-19 Infection, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 1,152
- Enrollment target
- 1
- Study location
NCT04474301: Recruiting study of Melanoma and COVID-19 Infection, sponsored by M.D. Anderson Cancer Center.
NCT04474301 is a study of Melanoma and COVID-19 Infection that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 1,152 participants, above the 702-participant average among 266 other Melanoma trials with a reported enrollment target (64% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04474301, a study of Melanoma and COVID-19 Infection, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 1,152 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose of this study is to gain an understanding of how experiences during the COVID-19 pandemic, regardless of COVID-19 status, may have impacted multiple domains of health-related quality of life and other areas such as COVID-19 specific psychological distress, and disruptions to health care, finances and social interactions. We will also evaluate the extent to which resiliency factors such as social support, perceived benefits under times of stress, and ability to manage stress may buffer associations between COVID-19 experiences and HRQoL. To meet these objectives, we have developed a 10-minute questionnaire that taps into these areas and is based on prior work addressing concerns of other pandemics or national crises. Participants will have previously consented to protocol PA15-0336 and have provided prior lifestyle data. This will allow us to connect the COVID-19 survey data with prior existing data.
Primary Outcome
Including exposure, risk factors, testing, isolation, seropositivity, hospitalization, or loss of family or friends.
Conditions Studied
Interventions
- OTHER Survey Administration
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,152 participants |
| Start Date | 2020-06-11 |
| Est. Completion | 2026-12-30 |
What NCT04474301 shows while recruiting
NCT04474301 is an observational study that tracks outcomes without assigning an intervention. Its 1,152 participants enrollment target places it among the larger protocols in the corpus, above the 702-participant average among 266 other Melanoma trials with a reported enrollment target (64% higher).
The record links to 2 conditions, with Melanoma appearing as the primary indexed condition, and to 1 intervention - of which Survey Administration is the first listed.
NCT04474301 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04474301 about?
NCT04474301 is a clinical study titled "Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic". The primary purpose of this study is to gain an understanding of how experiences during the COVID-19 pandemic, regardless of COVID-19 status, may have impacted multiple domains of health-related quality of life and other areas such as COVID-19 specific psychological distress, and disruptions to heal...
What is the current status of trial NCT04474301?
This trial is currently recruiting. The enrollment target is 1,152 participants. The study started on 2020-06-11. Estimated completion is 2026-12-30.
What conditions does trial NCT04474301 study?
This clinical trial studies the following conditions: Melanoma, COVID-19 Infection.
What interventions are being tested in trial NCT04474301?
The interventions under investigation include: Survey Administration (OTHER).
Who is sponsoring clinical trial NCT04474301?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04474301 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Melanoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04474301's enrollment target sits among peer trials
1,152 17th of 266 higher than 250 of 266 other Melanoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Melanoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
RECRUITING · NA
-
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
RECRUITING · Phase 2
-
Dabrafenib and/or Trametinib Rollover Study
RECRUITING · Phase 4
-
Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFED
RECRUITING · Phase 2
-
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
RECRUITING · Phase 1
-
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05564026 · 1,151 participants
Molecular Epidemiology of Pediatric Germ Cell Tumors
- NCT06408181 · 1,150 participants · Phase 3
APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia
- NCT06528314 · 1,150 participants · Phase 3
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- NCT07293559 · 1,150 participants
Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI